Kodiak Sciences KOD
NASDAQ KOD
$35.36 -1.00 (-2.75%)
As of: Sep 4, 2026 · 3:59 PM EDT

Kodiak Sciences (KOD) Accumulated Expenses (2017 - 2026)

Kodiak Sciences' (KOD) quarterly Accumulated Expenses came in at $9.2 million in Q1 2026, up 44.02% YoY from $6.4 million in Q1 2025, and up 18.28% on a QoQ basis from $7.8 million in Q4 2025.

Analysis

Kodiak Sciences (KOD) Accumulated Expenses (2017 - 2026) Analysis & Trends

Kodiak Sciences (KOD) has 10 years of Accumulated Expenses data on file, last reported at $9.2 million in Q1 2026.

  • Quarterly Accumulated Expenses rose 44.02% year-over-year to $9.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.2 million (up 44.02% YoY) and the FY2025 annual result came in at $7.8 million, up 261.73% from the prior year.
  • Accumulated Expenses rose to $9.2 million in Q1 2026, from $7.8 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $43.2 million in Q2 2022 to a low of $2.1 million in Q4 2024.
  • A 5-year average of $10.0 million and a median of $7.8 million in 2025 frame the typical range for Accumulated Expenses.
  • Annual changes were most pronounced in 2022 — Accumulated Expenses soared 1160.09% — and 2023, when it tumbled 91.82%.
  • Tracing KOD's Accumulated Expenses over 5 years: stood at $6.0 million in 2022, then soared by 44.9% to $8.7 million in 2023, then slumped by 75.2% to $2.1 million in 2024, then jumped by 261.73% to $7.8 million in 2025, then increased by 18.28% to $9.2 million in 2026.
  • The last three Accumulated Expenses figures came in at $9.2 million (Q1 2026), $7.8 million (Q4 2025), and $20.3 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Kodiak Sciences 2.21 Bn 2.21 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30.32 Mn
Mar 31, 2026 26.57 Mn
Dec 31, 2025 20.61 Mn
Sep 30, 2025 20.31 Mn
Jun 30, 2025 14.67 Mn
Mar 31, 2025 13.39 Mn
Dec 31, 2024 11.03 Mn
Sep 30, 2024 10.57 Mn
Jun 30, 2024 9.44 Mn
Mar 31, 2024 12.77 Mn
Dec 31, 2023 18.35 Mn
Sep 30, 2023 23.17 Mn
Jun 30, 2023 54.04 Mn
Mar 31, 2023 54.73 Mn
Dec 31, 2022 33.44 Mn
Sep 30, 2022 40.87 Mn
Jun 30, 2022 43.16 Mn
Mar 31, 2022 58.28 Mn
Dec 31, 2021 48.32 Mn
Sep 30, 2021 39.02 Mn